IGF-1在先天性肥厚性幽门狭窄中的表达被引量：1

The expression of IGF-1 in congenital hypertrophic pyloric stenosis

导出

摘要目的研究细胞因子IGF-1在先天性肥厚性幽门狭窄中的表达。方法应用RT-PCR方法,对16例先天性肥厚性幽门狭窄病例的幽门肌组织及相对应的胃壁肌肉组织的IGF-1mRNA表达水平进行半定量检测。结果幽门肌组织中IGF-1mRNA的水平为0.6858±0.1639,高于胃壁肌肉组织的0.4063±0.0935,差别有统计学意义(P<0.001)。结论先天性肥厚性幽门狭窄患儿幽门肌中IGF-1mRNA表达增加,可能在幽门肌肥厚的过程中起了一定的作用。 Objective：To investigate the level of insulin-like growth factor-1 mRNA in congenital hypertrophic pyloric stenosis（CHPS） in children.Methods：This study is based on 16 cases of CHPS that were diagnosised through type-B ultrasonic and surgical intervention.The semi-quantited in 16 cases of pyloric muscle compared to the gastric wall IGF-1 mRNA levels were muscle using reverse transcript polymerase chains reaction（RT-PCR）.Results：The IGF-1 mRNA level was 0.6858±0.1639 in pyloric muscle whileas that was 0.4063±0.0935 in corresponding gastric wall muscle（P0.001）.Conclusions：The up-regulation of IGF-1 expression may partly play a role in the hypertrophy of pyloric muscle in CHPS.

作者张建星李笃妙傅冷西林俊山宋非无冯建军许雅丽

机构地区福建医科大学附属第一医院小儿外科福建医科大学附属第一医院中心实验室

出处《中国优生与遗传杂志》 2011年第3期32-33,共2页 Chinese Journal of Birth Health & Heredity

基金福建省卫生厅青年科研基金项目(2007-2-2)

关键词先天性肥厚性幽门狭窄胰岛素样生长因子-1 逆转录聚合酶链反应儿童 Congenital hypertrophic pyloric stenosis（CHPS） Insulin-like growth factor-1（IGF-1） Reverse transcript polymerase chains reaction（RT-PCR） Children

分类号 R726.5 [医药卫生—儿科]

引文网络
相关文献

参考文献11

1Hemanz - Schulman M. Infantile hypertrophic pyloric stenosis [ J ]. Radiology, 2003 May,227 ( 2 ) : 319 - 331.
2郑莉莉,蔡威.先天性肥厚性幽门狭窄发病机制研究进展[J].临床儿科杂志,2007,25(5):408-411. 被引量：8
3Chen Y, Bomfeldt KE, Arner A, et al. Increase in insulin - like growth factor- 1 on hypertrophying smooth muscle[ Jl- Am J Physiol, 1994, 266 : E224 - E229.
4Jablonski J, et al. Study of insulin - like growth factor - 1 ( IGF - 1 ) and platelet - derived endothelial cell growth factor ( PDEGF ) ex- pression in children with infantile hypertrophic pylofic stenosis [ J ]. Med Sci Monit,2006 Jan, 12 ( 1 ) : CP,27 - 30.
5卢圣栋,主编.现代分子生物学技术[M].第2版.北京:中国协和医科大学出版,1999,9:69-70,459-460.
6Shima H, Ohshiro K, Purl P. Increased local synthesis of epidemml growth factors in infantile hypertrophic pyloric stenosis [ J ]. Pediatr Res,2000 Feb,47(2) :201 -207.
7Nino Guarino, Hideki Shima, Takaharu Oue, Prem Puri. Glial - de- rived growth factor signaling pathway in infantile hypertrophic pyloric stenosis[ J]. J Pediatr Surg,2000,35(6) :835 - 839.
8Shima H, Puri P. Increased expression of transforming growth factor - alpha in infantile hypertrophic pyloric stenosis I J l- Pediatr Surg Int, 1999,15(3) :198 -200.
9刘浩.神经生长因子受体在先天性肥厚性幽门狭窄的免疫组化观察[J].中华小儿外科杂志,2001,22(3):191-191. 被引量：7
10Guarino N, Yoneda A, Shima H, Puri P. Selective neurotrophin defi- ciency in infantile hypertrophic pyloric stenosis [ J ]. J Pediatr Surg, 2001 Aug,36(8) :1280 - 1284.

二级参考文献55

1LeRoith M D,沈钰如.胰岛素样生长因子的生理和病理意义[J].国外医学（内分泌学分册）,1993,13(2):84-86. 被引量：7
2刘浩，中华小儿外科杂志，1999年，20卷，12页
3李洁，中华小儿外科杂志，1998年，19卷，347页
4刘浩，中华小儿外科杂志，1997年，18卷，238页
5Ncxon AJ, Brower-Toland BD,Sandell LJ, Primary nucleotide structure of predominant and alternate splice forms of equine insulin-like growth factor I and their gene expression patterns in tissues[ J ]. Am J Vet Res,1999,60(8) : 1234-1241.
6Rajararn S, Baylink DJ, Mohan S.Insulin-like growth factor-binding proteins in serum and other biological fluids:regulation and functions[J]. Eudocr Rev, 1997,18(5) :801-831.
7Cotteril AM, The therapeutic potential of recombinant human insulinlike growth factor- 1[J].Clin Endocrinol, 1992,37 ( 1 ) : 11.
8Canalis EJ. Clinical review 35 growth factors and their potential clinical value[J].Clin Endocrinol Metaabe, 1992,75( 1 ) : 1.
9Estivariz CF, Zieyler TR. Nutrition and the insulin-like growth factor system[J]. Endocrine, 1997,7( 1 ) : 65.
10Laron Z, Arin S, Klipper-Aurbach Y, et al. Effects of insulin-like growth factors on linear growth, head circumference, and body fat in patients with Laron-type dwarfism[J]. Lancet, 1992,339(7) : 1258.